Search research articles
Contact Us
Filters
Showing results (331-340 of 408) with videos related to
Page
of 41
Sort By:
The Oncologist
|
July 4, 2025
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study
Andrew J Wagner, William D Tap, Sebastian Bauer, et al.
Genome Biology
|
October 16, 2014
Deletions of chromosomal regulatory boundaries are associated with congenital disease
Jonas Ibn-Salem, Sebastian Köhler, Michael I Love, et al.
British Journal of Cancer
|
August 30, 2017
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib
Heikki Joensuu, Jean-Yves Blay, Alessandro Comandone, et al.
Molecular Therapy. Nucleic Acids
|
March 23, 2017
Potent Anti-seizure Effects of Locked Nucleic Acid Antagomirs Targeting miR-134 in Multiple Mouse and Rat Models of Epilepsy
Cristina R Reschke, Luiz F Almeida Silva, Braxton A Norwood, et al.
Epilepsia
|
February 23, 2016
Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatricians
Adam Strzelczyk, Gerda Zschebek, Sebastian Bauer, et al.
Journal of Medicinal Chemistry
|
September 15, 2020
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design Approach
Jonas Lategahn, Julia Hardick, Tobias Grabe, et al.
Journal of Surgical Oncology
|
August 25, 2022
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis
Nicholas M Bernthal, John H Healey, Emanuela Palmerini, et al.
Journal of Clinical Medicine
|
April 30, 2021
Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives
Stefan K Zöllner, James F Amatruda, Sebastian Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2014
Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients
Andrew P Garner, Joseph M Gozgit, Rana Anjum, et al.
Scientific Reports
|
June 14, 2017
Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus
Rana Raoof, Eva M Jimenez-Mateos, Sebastian Bauer, et al.
Page
of 41
Search research articles
Search
Showing results (331-340 of 408) with videos related to
Sort By:
Page
of 41
The Oncologist
|
July 4, 2025
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study
Andrew J Wagner, William D Tap, Sebastian Bauer, et al.
Genome Biology
|
October 16, 2014
Deletions of chromosomal regulatory boundaries are associated with congenital disease
Jonas Ibn-Salem, Sebastian Köhler, Michael I Love, et al.
British Journal of Cancer
|
August 30, 2017
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib
Heikki Joensuu, Jean-Yves Blay, Alessandro Comandone, et al.
Molecular Therapy. Nucleic Acids
|
March 23, 2017
Potent Anti-seizure Effects of Locked Nucleic Acid Antagomirs Targeting miR-134 in Multiple Mouse and Rat Models of Epilepsy
Cristina R Reschke, Luiz F Almeida Silva, Braxton A Norwood, et al.
Epilepsia
|
February 23, 2016
Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatricians
Adam Strzelczyk, Gerda Zschebek, Sebastian Bauer, et al.
Journal of Medicinal Chemistry
|
September 15, 2020
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design Approach
Jonas Lategahn, Julia Hardick, Tobias Grabe, et al.
Journal of Surgical Oncology
|
August 25, 2022
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis
Nicholas M Bernthal, John H Healey, Emanuela Palmerini, et al.
Journal of Clinical Medicine
|
April 30, 2021
Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives
Stefan K Zöllner, James F Amatruda, Sebastian Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2014
Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients
Andrew P Garner, Joseph M Gozgit, Rana Anjum, et al.
Scientific Reports
|
June 14, 2017
Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus
Rana Raoof, Eva M Jimenez-Mateos, Sebastian Bauer, et al.
Page
of 41